Brodsky S, Eikelboom J, Hebert LA. Anticoagulant-related nephropathy. J Am Soc Nephrol. 2018;29(12):2787. https://doi.org/10.1681/ASN.2018070741

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brodsky SV, et al. Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis. 2009;54(6):1121–6. https://doi.org/10.1053/j.ajkd.2009.04.024

Article  PubMed  Google Scholar 

Glassock RJ. Anticoagulant-related nephropathy: it’s the real McCoy. Clin J Am Soc Nephrol. 2019;14(6):935. https://doi.org/10.2215/CJN.02470319

Article  PubMed  PubMed Central  Google Scholar 

Abt AB, Carroll LE, Mohler JH. Thin basement membrane disease and acute renal failure secondary to gross hematuria and tubular necrosis. Am J Kidney Dis. 2000;35(3):533–6. https://doi.org/10.1016/s0272-6386(00)70209-5

Article  CAS  PubMed  Google Scholar 

Golbin L, et al. Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases. Clin Kidney J. 2017;10(3):381–8. https://doi.org/10.1093/ckj/sfw133

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brodsky SV, Hebert LA. Anticoagulant-related nephropathy: is an AKI elephant hiding in plain view? J Am Coll Cardiol. 2016;68(21):2284–6. https://doi.org/10.1016/j.jacc.2016.09.926

Article  PubMed  Google Scholar 

Brodsky SV, et al. Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy. Kidney Res Clin Pract. 2017;36(4):387. https://doi.org/10.23876/j.krcp.2017.36.4.387

Jansky L, et al. Acute kidney injury and undiagnosed immunoglobulin A nephropathy after dabigatran therapy. Proc (Bayl Univ Med Cent). 2018;31(3):321–3. https://doi.org/10.1080/08998280.2018.1463036

Article  PubMed  Google Scholar 

Shafi ST, et al. A case of dabigatran-associated acute renal failure. WMJ. 2013;112(4):173–5.

PubMed  Google Scholar 

Bachellerie B, et al. Patient with acute renal injury presenting dabigatran overdose: hemodialysis for surgery. Ann Fr Anesth Reanim. 2014;33(1):44–6. https://doi.org/10.1016/j.annfar.2013.11.011

Article  CAS  PubMed  Google Scholar 

de Aquino Moura KB, et al. Anticoagulant-related nephropathy: systematic review and meta-analysis. Clin Kidney J. 2019;12(3):400–7. https://doi.org/10.1093/ckj/sfy133

Article  CAS  PubMed  PubMed Central  Google Scholar 

L’Imperio V, et al. Anticoagulant-related nephropathy: a pathological note. J Thromb Thrombolysis. 2018;46(2):260–3. https://doi.org/10.1007/s11239-018-1669-3

Article  CAS  PubMed  Google Scholar 

Brodsky SV, et al. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int. 2011;80(2):181–9. https://doi.org/10.1038/ki.2011.44

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brodsky SV, et al. Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract. 2010;115(2):c142–6. https://doi.org/10.1159/000312877

Article  CAS  PubMed  PubMed Central  Google Scholar 

An JN, et al. The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in korean patients. PLoS ONE. 2013;8(4):e57661. https://doi.org/10.1371/journal.pone.0057661

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Kalaitzidis RG, et al. Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity. Int Urol Nephrol. 2017;49:1401–7. https://doi.org/10.1007/s11255-017-1527-9

Article  PubMed  Google Scholar 

Brodsky SV, et al. Anticoagulant-related nephropathy in kidney biopsy: a single-center report of 41 cases. Kidney Med. 2019;1(2):51–6. https://doi.org/10.1016/j.xkme.2019.03.002

Article  PubMed  PubMed Central  Google Scholar 

Lim AK, Campbell DA. Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation. Int Urol Nephrol. 2013;45:561–70. https://doi.org/10.1007/s11255-012-0364-0

Article  CAS  PubMed  Google Scholar 

Brodsky S et al. Increased INR> 3.0 in patients on warfarin therapy is associated with acute changes in the serum creatinine and increased mortality rate. Blood. 2010;116(21):819. https://doi.org/10.1182/blood.V116.21.819.819

Chen S, et al. Anticoagulant-related nephropathy induced by direct-acting oral anticoagulants: Clinical characteristics, treatments and outcomes. Thromb Res. 2023;222:20–3. https://doi.org/10.1016/j.thromres.2022.12.002

Article  CAS  PubMed  Google Scholar 

Mitsuboshi S, et al. Differences in risk factors for anticoagulant-related nephropathy between warfarin and direct oral anticoagulants: Analysis of the Japanese adverse drug event report database. Br J Clin Pharmacol. 2021;87(7):2977–81. https://doi.org/10.1111/bcp.14688

Article  CAS  PubMed  Google Scholar 

Grams ME, et al. A meta-analysis of the association of estimated GFR, albuminuria, age, race, and sex with acute kidney injury. Am J Kidney Dis. 2015;66(4):591–601. https://doi.org/10.1053/j.ajkd.2015.02.337

Article  CAS  PubMed  PubMed Central  Google Scholar 

Greinacher A, et al. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Circulation. 1999;100(6):587–93. https://doi.org/10.1161/01.cir.100.6.587

Article  CAS  PubMed  Google Scholar 

Gajra A, Husain J, Smith A. Lepirudin in the management of heparin-induced thrombocytopenia. Expert Opin Drug Metab Toxicol. 2008;4(8):1131–41. https://doi.org/10.1517/17425255.4.8.1131

Article  CAS  PubMed  Google Scholar 

Greinacher A. Heparin-induced thrombocytopenia. N Engl J Med. 2015;373(3):252–61. https://doi.org/10.1056/NEJMc1510993

Article  CAS  PubMed  Google Scholar 

Arepally GM. Heparin-induced thrombocytopenia. Blood. 2017;129(21):2864–72. https://doi.org/10.1182/blood-2016-11-709873

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Mieghem NM, et al. Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR. N Engl J Med. 2021;385(23):2150–60. https://doi.org/10.1056/NEJMoa2111016

Article  PubMed  Google Scholar 

Derebail VK, Rheault MN, Kerlin BA. Role of direct oral anticoagulants in patients with kidney disease. Kidney Int. 2020;97(4):664–75. https://doi.org/10.1016/j.kint.2019.11.027

Article  CAS  PubMed  Google Scholar 

Chan Y-H, et al. Acute kidney injury in Asians with atrial fibrillation treated with dabigatran or warfarin. J Am Coll Cardiol. 2016;68(21):2272–83. https://doi.org/10.1016/j.jacc.2016.08.063

Article  CAS  PubMed  Google Scholar 

Shin J-I, et al. Direct oral anticoagulants and risk of acute kidney injury in patients with atrial fibrillation. J Am Coll Cardiol. 2018;71(2):251–2. https://doi.org/10.1016/j.jacc.2017.10.089

Article  PubMed  PubMed Central  Google Scholar 

Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385–96. https://doi.org/10.2165/00002018-200629050-00003

Article  PubMed  Google Scholar 

Sakaeda T, et al. Data mining of the public version of the FDA Adverse Event Reporting System. Int J Med Sci. 2013;10(7):796. https://doi.org/10.7150/ijms.6048

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hartnell NR, Wilson JP. Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration. 2004, Wiley Online Library.

Pariente A, et al. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases the notoriety bias. Drug Saf. 2007;30:891–8. https://doi.org/10.2165/00002018-200730100-00007

Article  PubMed  Google Scholar 

Wang H-W, et al. An experimental investigation of masking in the US FDA adverse event reporting system database. Drug Saf. 2010;33:1117–33. https://doi.org/10.2165/11584390-000000000-00000

Article  PubMed  Google Scholar